BridgeBio Pharma LLC - Aug 11, 2025 SCHEDULE 13D Report for BridgeBio Oncology Therapeutics, Inc. Common Stock, $0.0001 par value (BBOT)

Filing Manager: BridgeBio Pharma LLC
Reporting Manager: BridgeBio Pharma LLC
Security: BridgeBio Oncology Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol: BBOT
Shares outstanding: 79.3M shares
Disclosed Ownership: 13.9M shares
Ownership: 17.5%
Form type: SCHEDULE 13D
Date filed: 8/18/2025, 05:41 PM
Date of event: Aug 11, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BridgeBio Pharma LLC	17.5%	13.9M	13.9M	0	/s/ Neil Kumar	Neil Kumar, Chief Executive Officer	0002076615
BridgeBio Pharma, Inc.	17.5%	13.9M	13.9M	0	/s/ Neil Kumar	Neil Kumar, Chief Executive Officer	0001743881